血府逐瘀汤加减治疗中风后痉挛性瘫痪的疗效观察

杨子萱

摘要：目的：探究采用血府逐瘀汤加减治疗中风后痉挛性瘫痪的临床价值。方法：将2020年4月-2021年3月于我院脑病科接受治疗的86例中风后痉挛性瘫痪患者作为此次研究对象。在正式开展研究之前，按患者所接受治疗方法不同将其划分为常规组和实验组，每组各划入43例患者。针对常规组患者，主要予以巴氯芬片治疗，而实验组则予以血府逐瘀汤加减治疗，最后对两组患者经不同疗法治疗后的相关指标进行对比分析。结果：经对比数据分析得出：实验组患者经血府逐瘀汤加减治疗后的各项指标明显优于常规组，并且各对比数据间差异显著，P<0.05，具有统计学意义。结论：血府逐瘀汤加减治疗中风后痉挛性瘫痪具有积极的临床价值，建议在临床实践中大力推广和应用。

关键词：血府逐瘀汤加减;中风后痉挛性瘫痪;临床疗效

Objective： To explore the clinical value of Xuefu Zhuyu Decoction in the treatment of spastic paralysis after stroke. Methods： from April 2020 to March 2021， 86 patients with spastic paralysis after stroke were selected as the research objects. Before the formal study， the patients were divided into the conventional group and the experimental group according to the different treatment methods， with 43 patients in each group. The conventional group was mainly treated with baclofen tablets， while the experimental group was treated with Xuefu Zhuyu Decoction. Finally， the related indicators of the two groups were compared and analyzed after different treatments. Results： after the analysis of comparative data， the indexes of the experimental group were significantly better than those of the conventional group， and the differences between the comparative data were significant， P < 0.05， with statistical significance. Conclusion： the modified Xuefu Zhuyu decoction has positive clinical value in the treatment of spastic paralysis after stroke， and it is recommended to be vigorously promoted and applied in clinical practice.

Key words： Xuefu Zhuyu Decoction; Spastic paralysis after stroke; Clinical effect

中風患者在发病后极易出现痉挛性瘫痪，其中临床中也被称为上运动神经元性瘫痪，不仅会影响预后，甚至可能引发废用性肌萎缩，导致患者生活质量大大降低[1]。经大量临床实践研究后发现，血府逐瘀汤加减治疗该疾病的临床效果显著。特此，本文展开研究，并做出如下报告：

1资料与方法

1.1一般资料

参与本次研究的患者均为2020年4月-2021年3月于我院脑病科接受治疗的中风后痉挛性瘫痪患者，并随机划分为实验组和常规组两组。通过对两组患者一般资料进行对比分析得出：常规组患者中有男性22例、女性21例，平均年龄为（66.24±2.04）岁，平均病程为（2.34±0.31）个月;实验组患者中有男性23例、女性20例，平均年龄为（66.35±2.01）岁，平均病程为（2.22±0.41）个月。……